GALWAY, IRELAND--November 2, 2021--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Novartis International AG (NYSE:NVS) (Basel, Switzerland) has inked a new deal to boost the manufacturing capacity of the Pfizer-BioNTech COVID-19 vaccine, COMINARTY, at its sterile fill-finish plant in Ljubljana, Slovenia.

Within this article: Details new manufacturing deal, new location, estimated capacity, related CureVac COVID-19 vaccine news